195 results
Page 2 of 10
6-K
EX-99.1
vyo jczj96i
18 Oct 23
Current report (foreign)
6:20am
6-K
xmhjtsct
2 Oct 23
Current report (foreign)
6:17am
6-K
f6vww8rw
28 Sep 23
Current report (foreign)
6:17am
6-K
rjkpp7g5fs23ylfk
11 Sep 23
Current report (foreign)
6:50am
6-K
qi89uaj
1 Aug 23
Current report (foreign)
6:10am
6-K
EX-99.1
3ehorsa8lmawneqtjg
27 Jul 23
Current report (foreign)
6:05am
6-K
EX-99.1
wj8r3wi 0qtq9ab
12 Jul 23
Current report (foreign)
6:07am
6-K
EX-99.1
hk2vo6 3fkcb
6 Jul 23
Current report (foreign)
6:18am
6-K
gqg780750 xvh
28 Jun 23
Current report (foreign)
6:02am
6-K
EX-99.1
f78r8hf2k1 f3d8he5oy
23 Jun 23
Current report (foreign)
6:13am
6-K
ezu8m oa10
30 May 23
Current report (foreign)
6:20am
6-K
EX-99.1
kqjgt2yqiwvhjz
30 May 23
Current report (foreign)
6:19am
6-K
EX-99.1
210ix7p86okhh503
30 May 23
Current report (foreign)
6:14am
6-K
EX-99.1
3z0b10j0
30 May 23
Current report (foreign)
6:11am
6-K
alxni7 x5
17 May 23
Current report (foreign)
6:02am
6-K
w1cgzwgnhso4t07mle9
11 May 23
Current report (foreign)
6:10am
6-K
gpyzcn7
11 May 23
Current report (foreign)
6:07am
6-K
EX-99.1
qg0xyzj6izf78vgk8
11 May 23
Current report (foreign)
6:07am
6-K
EX-99.1
pr54qqi2ki lyqw
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am